Sepax Technologies invites you to meet at 2026 BPD Singapore
As biologics expand into the Asia-Pacific region, downstream purification—a critical component of CMC commercialization—faces new challenges and opportunities. 2026 BPD Singapore will launch on 9 22–23.
As a key platform for Chinese bioprocessing companies to connect with Southeast Asian and global markets, the event will host over 500 attendees and 50 speakers. Featuring technical forums, CEO closed-door sessions, BPD NIGHT, and 1:1 meetings, it will engage decision-makers from MNCs, Chinese biotech firms, local Southeast Asian enterprises, upstream suppliers, industry associations, regulatory bodies, and research institutions. The focus will be on APAC capacity planning, regional compliance, process scale-up, and supply chain localization.
Meeting Details
Booth No.: S05
Meeting time: 9/22-23
Venue: Heliconia Junior Ballroom, Sands Expo and Convention Centre, Marina Bay Sands, Singapore 3411-3513
Exclusive Registration
Sepax Technologies, a leading manufacturer of downstream purification media for biologics, will attend the conference in Singapore. We will showcase our integrated industrial purification solutions, including Protein A affinity, ion exchange, and hydrophobic interaction chromatography media. We look forward to meeting with CMC leaders and process development professionals from pharmaceutical companies across the Asia-Pacific region to explore innovations in biopharmaceutical manufacturing processes and opportunities for supply chain collaboration.
